Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Q2 2025 Earnings Call Transcript August 5, 2025
Madrigal Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-1.90395, expectations were $-3.48.
Operator: Good morning, and thank you for standing by. Welcome to Madrigal Pharmaceuticals Second Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, today’s conference call is being recorded. I would now like to introduce Ms. Tina Ventura, Chief Investor...
